British Columbia Gazette Part II — B.C. Reg. 156/2009
B.C. Reg. 156/2009
British Columbia — Gazette
Copyright © Queen's Printer,
Victoria, British Columbia, Canada
Licence
Disclaimer
Volume 52, No. 8
B.C. Reg. 156/2009
The British Columbia Gazette,
Part II
April 21, 2009
B.C. Reg. 156/2009 , deposited April 9, 2009, pursuant to the HEALTH PROFESSIONS ACT [Section 12 (2)]. Ministerial Order M130/2009, dated April 8, 2009.
I, George Abbott, Minister of Health Services, order that the Naturopathic Physicians Regulation, B.C. Reg. 282/2008, is amended as set out in the attached appendix.
— G. ABBOTT, Minister of Health Services .
Appendix
Section 1 of the Naturopathic Physicians Regulation, B.C. Reg. 282/2008, is amended
(
a) by repealing the definition of "naturopathic medicine" and substituting the following:
"naturopathic medicine" means the health profession in which a person provides the services of prevention, assessment and treatment of an individual's diseases, disorders and conditions using education and naturopathic techniques, therapies or therapeutics to stimulate or support healing processes and promote, maintain or restore the overall health of the individual; , and
(
b) by adding the following
definitions:
"compound" means
(
a) in respect of a drug, to mix with one or more other ingredients, and
(
b) in respect of a therapeutic diet, to mix two or more ingredients;
"dispense" has the same meaning as in the Pharmacy Operations and Drug Scheduling Act , but excludes a sale, as defined in that Act;
"drug" means, except in the definition of "substance", a drug
(
a) specified in
Schedule I of the Drug Schedules Regulation, B.C. Reg. 9/98, other than a drug set out in the
Schedule of this regulation, or
(
b) specified in
Schedule II of the Drug Schedules Regulation;
"enteral instillation" means instillation directly into the gastrointestinal tract;
"minor surgery" means a surgical procedure that
(
a) is performed, for a diagnostic or therapeutic purpose, on a superficial anatomical structure, and
(
b) does not involve
(
i) sedation, general anaesthesia or respiratory assistance, or
(ii) a material risk to life;
"parenteral instillation" means instillation directly into the blood stream;
"prescribe" means to issue a prescription, as defined in the Pharmacy Operations and Drug Scheduling Act ;
"substance" includes air and water, but excludes a drug specified in
Schedule I, IA, II or IV of the Drug Schedules Regulation.
Section 5 is repealed and the following substituted:
Restricted activities
(1) A registrant in the course of practising naturopathic medicine May do any of the following:
(
a) use naturopathic techniques to make a diagnosis identifying, as the cause of signs or symptoms of an individual, a disease, disorder or condition;
(
b) perform a procedure on tissue
(
i) below the dermis, or
(ii) below the surface of a mucous membrane;
(
c) move a joint of the spine beyond the limits the body can voluntarily achieve but within the anatomical range of motion using a high velocity, low amplitude thrust;
(
d) administer a substance
(
i) by injection,
(ii) by inhalation,
(iii) by irrigation,
(iv) by enteral instillation or parenteral instillation, or
(
v) using a hyperbaric chamber;
(
e) put an instrument or a device or finger
(
i) into the external ear canal, up to the eardrum,
(ii) beyond the point in the nasal passages where they normally narrow,
(iii) beyond the opening of the urethra,
(iv) beyond the labia majora,
(
v) beyond the anal verge, or
(vi) into an artificial opening into the body;
(
f) put into the external ear canal, up to the eardrum, a substance that is under pressure;
(
g) apply
(
i) ultrasound for diagnostic or imaging purposes, including any application of ultrasound to a fetus,
(ii) electricity for the purposes of
(
A) destroying tissue in the course of minor surgery, or
(
B) defibrillation in the course of emergency cardiac care, or
(iii) X-rays for diagnostic or imaging purposes, excluding X-rays for the purpose of computerized axial tomography;
(
h) issue an instruction or authorization for another person to perform, in respect of a named individual, a restricted activity specified in paragraph (g) (
i) or (iii);
(
i) in respect of a drug,
(
i) prescribe the drug,
(ii) compound the drug,
(iii) dispense the drug, or
(iv) administer the drug by any method;
(
j) if nutrition is administered by enteral instillation or parenteral instillation,
(
i) select ingredients for a therapeutic diet,
(ii) compound a therapeutic diet, or
(iii) dispense a therapeutic diet;
(
k) conduct challenge testing for allergies
(
i) that involves injection, scratch tests or inhalation, if the individual being tested has not had a previous anaphylactic reaction, or
(ii) by any method, if the individual being tested has had a previous anaphylactic reaction;
(
l) conduct desensitizing treatment for allergies
(
i) that involves injection, scratch tests or inhalation, if the individual being tested has not had a previous anaphylactic reaction, or
(ii) by any method, if the individual being tested has had a previous anaphylactic reaction.
(2) Only a registrant May practise naturopathic medicine.
Section 6 is repealed and the following substituted:
Limits or conditions on services and restricted activities
(1) A registrant May perform only surgery that is minor surgery.
(2) A registrant May prescribe, compound, dispense or administer a drug only if
(
a) standards, limits and conditions have been established, under
section 19 (1) (
k) or (
l) of the Act, respecting the prescribing, compounding, dispensing and administering of drugs by registrants,
(
b) the standards, limits and conditions described in paragraph (
a) are established on the recommendation of a committee that
(
i) is established under
section 19 (1) (
t) of the Act, and
(ii) has the duty and power to develop, review and recommend those standards, limits and conditions, and
(
c) the registrant has successfully completed a certification program established, required or approved under the bylaws to ensure that registrants are qualified and competent to prescribe, compound, dispense or administer a drug.
(3) A registrant May perform an activity described in
section 5 (1) (d) (v), (
k) or (
l) only if
(
a) standards, limits and conditions have been established, under
section 19 (1) (
k) or (
l) of the Act, respecting the activity, and
(
b) the standards, limits and conditions described in paragraph (
a) are established on the recommendation of a committee that
(
i) is established under
section 19 (1) (
t) of the Act, and
(ii) has the duty and power to develop, review and recommend those standards, limits and conditions.
4 The following
Schedule is added:
Schedule
Excluded
Schedule I Drugs
Acetohexamide
Adalimumab
Adefovir
Agalsidase alfa
Aldesleukin
Alemtuzumab
Alfentanil
Alkyl nitrites
Alprazolam
Altretamine
Amifostine and its salts
Aminoglutethimide
Aminopterin and its salts
Aminopyrine and its derivatives
Amprenavir and its salts and derivatives
Amsacrine and its salts
Anagrelide and its salts
Anakinra and its salts and derivatives
Anastrozole
Ancestim
Anileridine
Anti-thymocyte globulin
Atazanavir and its salts
Atracurium besilate
Auranofin
Aurothioglucose
Basiliximab
Bevacizumab
Bicalutamide
Bleomycin
Bortezomib
Bromazepam and its salts
Buprenorphine
Buserelin and its salts
Busulfan
Butalbital
Butorphanol
Cabergoline and its salts
Capecitabine and its salts and derivatives
Carboplatin
Carmustine
Cetrorelix and its salts
Cetuximab
Chlorambucil and its salts and derivatives
Chlordiazepoxide and its salts
Chlorisondamine and its salts
Choriogonadotripin alfa
Cinacalcet and its salts
Cisplatin
Cladribine and its salts
Clobazam and its salts
Clonazepam and its salts
Clorazepic acid and its salts
Codeine when prescribed as a single entity or when included in a preparation containing 60 mg or more per dosage unit
Cyclophosphamide
Cycloserine
Cyclosporine
Cytarabine and its salts
Dacarbazine
Daclizumab
Dactinomycin
Daunorubicin and its salts
Delavirdine and its salts
Desflurane
Dexrazoxane and its salts
Diazepam and its salts
Didanosine and its salts and derivatives
Diethylstilbestrol and its derivatives
Dihydrotachysterol
Dinoprostone and its salts and derivatives
Docetaxel and its derivatives
Doxacurium chloride
Doxercalciferol and its derivatives
Doxorubicin and its salts
Droperidol and its salts
Edrophonium chloride
Efavirenz
Emtricitabine
Enflurane
Enfuvirtide
Epirubicine and its salts
Erythropoietin
Estazolam and its salts
Estramustine and its salts
Etanercept
Ethambutol and its salts
Ethchlorvynol
Ethionamide and its salts
Ethoheptazine and its salts
Etoposide and its derivatives
Exemestane
Fenfluramine and its salts
Fentanyl
Filgrastim
Flucytosine
Fludarabine and its salts and derivatives
Flumazenil
Fluorouracil and its derivatives for parenteral use only
Flurazepam and its salts
Flutamide
Follicle stimulating hormone
Formestane and its salts and derivatives
Fulvestrant
Gallamine triethiodide
Ganirelix and its salts and derivatives
Gefitinib
Gemcitabine and its salts
Glatiramer and its salts
Gold and its salts
Goserelin and its salts
Halazepam and its salt
Halofantrine and its salts
Halothane
Hydrocodone (dihydrocodeinone)
Hydromorphone (dihydromorphone)
Hydroxychloroquine and its salts
Idarubicin and its salts
Ifosfamide
Imatinib and its salts
Imiglucerase
Indinavir and its salts
Infliximab
Interferon
Iproniazid and its salts
Irinotecan and its salts
Isoflurane
Ivermectin and its derivatives
Kanamycin and its salts and derivatives
Ketamine and its salts
Ketazolam and its salts
Lamivudine and its salts
Laronidase
L-Asparaginase
Leflunomide and its salts
Letrozole
Leuprolide and its salts
Levallorphane and its salts
Levamisole and its salts
Levorphanol
Lincomycin and its salts and derivatives
Linezolid and its salts
Lomefloxacin and its salts
Lomustine
Lopinavir
Loracarbef and its salts and derivatives
Lorazepam and its salts
Mazindol and its salts
Mecamylamine and its salts
Mechlorethamine and its salts
Melanoma therapeutic vaccine
Melphalan
Menotropins (human)
Meperidine (pethidine)
Mercaptopurine
Meropenem and its salts and derivatives
Mesna
Metaraminol bitartrate
Methadone
Methaqualone
Midazolam and its salts
Midodrine and its salts
Miglustat
Mitomycin and its salts
Mitotane (o,p'-DDD)
Mitoxantrone and its salts
Mivacurium chloride
Molgramostim
Morphine
Muromonab-CD3
Mycophenolic acid and its salts and derivatives
Nalmefene and its salts
Nelfinavir and its salts
Neostigmine salts
Netilmicin and its salts and derivatives
Nevirapine and its salts
Nikethamide
Nilutamide
Nitrazepam and its salts
Normethadone
Octreotide
Oxazepam and its salts
Oxycodone
Paclitaxel and its derivatives
Palivizumab
Pamidronic acid and its salts
Pancuronium and its salts
Pegfilgrastim
Pemetrexed and its salts
Pentamidine and its salts
Pentazocine
Pentolinium tartrate
Pentostatin and its salts
Perflutren
Phentolamine and its salts
Pipobroman
Porfimer and its salts
Pralidoxime and its salts
Prazepam and its salts
Prodilidine and its salts
Propofol
Propoxyphene
Pyrazinamide
Pyridostigmine bromide
Raltitrexed and its salts and derivatives
Rasburicase
Rifabutin and its salts
Riluzole and its salts
Ritonavir
Rituximab
Rocuronium bromide
Rofecoxib
Saquinavir and its salts and derivatives
Sargramostin
Sevelamer hydrochloride
Sirolimus and its derivatives
Sodium aurothiomalate
Stavudine
Streptozocin
Succinylcholine and its salts
Sufentanil
Suxamethonium chloride
Tacrolimus and its derivatives
Tegafur and its salts
Temazepam and its salts
Temozolomide and its salts
Teniposide
Tenofovir and its salts and derivatives
Thalidomide
Thiocarlide
Thioguanine
Thiotepa
Tiludronic acid and its salts
Tipranavir and its salts
Topotecan and its salts
Toremifene and its salts
Trastuzumab
Treosulfan
Treprostinil and its salts
Tretamine
Triazolam and its salts
Trimethaphan camsylate
Trimetrexate and its salts
Troglitazone
Tubocurarine and its salts
Valrubicin and its derivatives
Vecuronium bromide
Viomycin and its salts and derivatives
Zalcitabine and its salts
Zidovudine
Zoledronic acid and its salts and derivatives
Copyright © 2009: Queen's Printer, Victoria, British Columbia, Canada